Gemma Unwin

Dr. Gemma Unwin

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2007 in Journal of Intellectual Disability Research
Verified
Journal Article
Closed access
PDF file
SDS. Deb
S. Deb
SSS. K. Sohanpal
S. K. Sohanpal
RSR. Soni
R. Soni
LTL. Len tre
L. Len tre
GUGemma Unwin
Gemma Unwin

20 March 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YCYen-Fu Chen
Yen-Fu Chen
GBGeorge Bramley
George Bramley
GUGemma Unwin
Gemma Unwin
DHDalvina Hanu-Cernat
Dalvina Hanu-Cernat
JDJanine Dretzke
Janine Dretzke
RLRichard Lilford
Richard Lilford
Chronic migraine is a debilitating headache disorder that has significant impact on quality of life. Stimulation of peripheral nerves is increasingly being used to treat chronic refractory pain including headache disorders. This systematic review examines the effectiveness and adverse effects of occipital nerve stimulation (ONS) for chronic migraine. Databases, including the Cochrane Library, MEDLINE, EMBASE, CINAHL and clinical trial registers were searched to September 2014. Randomized controlled trials (RCTs), other controlled and uncontrolled observational studies and case series (n≥ 10) were eligible. RCTs were assessed using the Cochrane risk of bias tool. Meta-analysis was carried out using a random-effects model. Findings are presented in summary tables and forest plots. Five RCTs (total n=402) and seven case series (total n=115) met the inclusion criteria. Pooled results from three multicenter RCTs show that ONS was associated with a mean reduction of 2.59 days (95% CI 0.91 to 4.27, I2=0%) of prolonged, moderate to severe headache per month at 3 months compared with a sham control. Results for other outcomes generally favour ONS over sham controls but quantitative analysis was hampered by incomplete publication and reporting of trial data. Lead migration and infections are common and often require revision surgery. Open-label follow-up of RCTs and case series suggest long-term effectiveness can be maintained in some patients but evidence is limited. While the effectiveness of ONS compared to sham control has been shown in multiple RCTs, the average effect size is modest and may be exaggerated by bias as achieving effective blinding remains a methodological challenge. Further measures to reduce the risk of adverse events and revision surgery are needed. this systematic review is an update and expanded work of part of a broader review registered with PROSPERO. Registration No. CRD42012002633.

1 April 2016 in Research in Developmental Disabilities
Verified
Journal Article
Closed access
GUGemma Unwin
Gemma Unwin
ITIoanna Tsimopoulou
Ioanna Tsimopoulou
BKBiza Stenfert Kroese
Biza Stenfert Kroese
SASabiha Azmi
Sabiha Azmi

2 November 2007 in Journal of Intellectual Disability Research
Verified
Journal Article
Closed access
PDF file
SDS. Deb
S. Deb
RCR. Chaplin
R. Chaplin
SSS. Sohanpal
S. Sohanpal
GUGemma Unwin
Gemma Unwin
RSR. Soni
R. Soni
LLL. Lenotre
L. Lenotre

7 June 2007 in Journal of Intellectual Disability Research
Verified
Journal Article
Closed access
PDF file
SSS. K. Sohanpal
S. K. Sohanpal
SDS. Deb
S. Deb
CTC. Thomas
C. Thomas
RSR. Soni
R. Soni
LLL. Lenôtre
L. Lenôtre
GUGemma Unwin
Gemma Unwin

1 March 2014 in Research in Developmental Disabilities
Verified
Journal Article
Closed access
SDShoumitro Deb
Shoumitro Deb
BFBaldeep K. Farmah
Baldeep K. Farmah
EAEbrahim Arshad
Ebrahim Arshad
TDTanya Deb
Tanya Deb
MRMeera Roy
Meera Roy
GUGemma Unwin
Gemma Unwin